|
C18ORF8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.019600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.797000E-01 |
| Normal-vs-Stage2 |
3.749600E-01 |
| Normal-vs-Stage3 |
8.188800E-01 |
| Normal-vs-Stage4 |
5.140800E-01 |
| Stage1-vs-Stage2 |
4.097200E-01 |
| Stage1-vs-Stage3 |
7.705000E-01 |
| Stage1-vs-Stage4 |
6.423600E-01 |
| Stage2-vs-Stage3 |
5.801000E-01 |
| Stage2-vs-Stage4 |
2.584400E-01 |
| Stage3-vs-Stage4 |
4.899600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.633600E-01 |
| Normal-vs-AfricanAmerican |
7.393000E-01 |
| Normal-vs-Asian |
5.964800E-01 |
| Caucasian-vs-AfricanAmerican |
5.430400E-01 |
| Caucasian-vs-Asian |
6.564800E-01 |
| AfricanAmerican-vs-Asian |
5.451200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.892800E-01 |
| Normal-vs-Female |
6.072800E-01 |
| Male-vs-Female |
3.516800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.350800E-01 |
| Normal-vs-Extreme_Weight |
2.589400E-01 |
| Normal-vs-Obese |
8.276200E-01 |
| Normal-vs-Extreme_Obese |
8.528200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.858000E-01 |
| Normal_Weight-vs-Obese |
7.345800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.410400E-01 |
| Extreme_Weight-vs-Obese |
3.166400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.412600E-01 |
| Obese-vs-Extreme_Obese |
7.953400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.256200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.226000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.383600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.892800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.003400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.296000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.518200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.652000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.425000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.231200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.758800E-01 |
| Normal-VS-Type2 PRCC |
7.405700E-02 |
| Normal-VS-KIRP CIMP |
8.398200E-01 |
| Normal-VS-Unclassified PRCC |
4.685400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.279300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.512600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.505400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.445030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.232400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.761800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.979000E-01 |
| Normal-vs-N1 |
7.902600E-01 |
| Normal-vs-N2 |
3.391800E-01 |
| N0-vs-N1 |
6.705600E-01 |
| N0-vs-N2 |
2.864800E-01 |
| N1-vs-N2 |
2.598000E-01 |
|
|
